Clin2
NCT06104631Possibly a fitRecruiting

Testing a treatment for IBS-like symptoms in Crohn's remission

Irritable Bowel Syndrome-like SymptomsCrohn Disease Remission

Part of Digestive system clinical trials.

This study tests whether a new treatment can reduce IBS-like symptoms, such as belly pain and bloating, in people whose Crohn's disease is in remission. It aims to improve your quality of life without targeting active Crohn's inflammation.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • Your Crohn's disease has been in remission (no active inflammation) for at least 3 months without using steroids.
  • You have irritable bowel syndrome (IBS)-like symptoms like belly pain or bloating.
  • You are not taking NSAIDs (like ibuprofen), steroids, opioids, or antibiotics currently or recently.
  • You have a smartphone or tablet to use study apps and can read and write in French.
  • You agree to keep your current medications and lifestyle the same during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05097872Recruiting
Diet trial for IBS with non-constipation symptoms

This study tests whether a specific diet plan can improve symptoms in people with IBS that is not constipation (IBS-D or IBS-M). If you qualify, you’ll complete symptom questionnaires and follow the study diet for the trial period to see if symptoms improve.

Leuven
NCT02421705Recruiting
Brain-gut sensitivity study in IBS and inflammatory bowel disease

This study checks how sensitive your gut is to normal stimuli in people with IBS, ulcerative colitis, Crohn’s disease, and in healthy volunteers. Results may help researchers understand why some people feel more abdominal discomfort and how that connects to inflammatory bowel conditions.

Leuven, Vlaams-Brabant
NCT04946448Recruiting
Test a Crohn’s diet and biologic medicine combination

This study tests whether combining a specific diet with biologic medicines can reduce active inflammation and symptoms of Crohn’s disease. It may help people who still have active disease in the bowel despite prior care.

Leuven
NCT05120752Recruiting· Phase 3
Low FODMAP diet trial for IBS without lactose intolerance

This trial tests whether eating a low-FODMAP diet can reduce IBS symptoms in people who do not have lactose intolerance. It aims to improve moderate-to-severe IBS symptoms by changing what kinds of carbohydrates you eat.

Jette, Brussels Capital
NCT06636513Recruiting
Testing SMT04 for irritable bowel syndrome

This trial tests a new treatment called SMT04 for people with irritable bowel syndrome (IBS), specifically the diarrhea or mixed types. It may help reduce symptoms like abdominal pain and changes in bowel habits.

Singapore, Singapore
NCT07556718Recruiting· Phase 2
Amitriptyline for IBS-like Symptoms in Stable Crohn's Disease

This study tests whether a medication called amitriptyline can help reduce belly pain and bowel problems in people whose Crohn's disease is well-controlled. Amitriptyline is an older antidepressant that may help with pain and bowel symptoms even when inflammation is quiet.

Ann Arbor, Michigan

Hear when a new Irritable Bowel Syndrome-like Symptoms trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.